Sort
64,565 grants matching “drug discovery”
Preclinical development of a novel small molecule inhibitor of Alzheimer's disease-related cognitive impairment
$1,516,817D. Martin Watterson · Northwestern University At Chicago · U01 · FY2022 · AG
Organic Pseudometals to Sustain and Transform Small-Molecule Drug Synthesis
$1,516,500Richard Liu · Harvard University · DP2 · FY2025 · GM
Molecular and Cellular Mechanisms of Osteoporosis
$1,516,128Stavros C. Manolagas · Univ Of Arkansas For Med Scis · P01 · FY2015 · AG
Defining pediatric intestinal failure natural history
$1,515,663Simon Horslen · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · FD
Modeling diabetes using an integrated plate system
$1,515,000James M Wells · Cincinnati Childrens Hosp Med Ctr · UH3 · FY2022 · DK
Genetic Modifiers of Initiation and Progression of Mammary Cancer
$1,513,839Kent W Hunter · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
$1,513,786Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Clark Atlanta University Biomedical Science Development
$1,513,670Carlton E. Brown · Clark Atlanta University · G12 · FY2009 · RR
FAMILIAL PARKINSON'S DISEASE: CLUES TO PATHOGENESIS
$1,513,192Brigham And Women'S Hospital · P50 · FY2003 · NS
Contraception by Blockade of Periovulatory Events in Primates
$1,512,284Richard L Stouffer · Oregon Health & Science University · U54 · FY2012 · HD
Contraception by Blockade of Periovulatory Events in Primates
$1,512,284Richard L Stouffer · Oregon Health & Science University · U54 · FY2016 · HD
Contraception by Blockade of Periovulatory Events in Primates
$1,512,284Richard L Stouffer · Oregon Health & Science University · U54 · FY2015 · HD
Vascular Biology in Cancer
$1,512,233Pengnian Lin · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Experimental Therapeutics of Anti-Cancer Agents with Phase I Emphasis
$1,512,192William E. Carson · Ohio State University · UM1 · FY2018 · CA
CDI Type II: Cyber-Engineering Functional Nanoparticles for Targeted Drug Delivery
$1,512,150Roland Faller · University Of California-Davis · · FY2009 · ENG
Dietary Biomarkers Development Center at Harvard University
$1,512,125Frank B Hu · Harvard School Of Public Health · U2C · FY2021 · DK
Technolgy Implementation
$1,512,032Hanlee Ji · Stanford University · P01 · FY2015 · HG
Development of Innovative Resources to Advance MDS Research
$1,511,993Marie Bleakley · Fred Hutchinson Cancer Center · RC2 · FY2024 · DK
Molecular Pathogenesis
$1,511,881Edward H Oldfield · Neurological Disorders And Stroke · Z01 · FY2007 · NS
Target Identification via Haplo Insufficiency Profiling
$1,511,752Stanford University · R33 · FY2002 · CA
Center for Testing Potential Anti-Aging Interventions
$1,511,552Randy Strong · University Of Texas Hlth Science Center · U01 · FY2020 · AG
Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis
$1,511,058Gregory Paul Downey · National Jewish Health · UH3 · FY2021 · TR
Novel Protease Inhibitors as SARS Therapeutics
$1,510,698Michael E. Johnson · University Of Illinois At Chicago · P01 · FY2008 · AI
Molecular and Cellular Mechanisms of Vascular Anomalies
$1,510,559Bjorn R Olsen · Harvard Medical School · P01 · FY2010 · AR
Planning Study for the Development of Sigma 2 ligands as Analgesics
$1,510,066Kevin Joseph Tidgewell · University Of Kentucky · R61 · FY2023 · NS